Template:KDRG: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 34: Line 34:
#[[Aprocitentan]]
#[[Aprocitentan]]
#[[WINREVAIR]]
#[[WINREVAIR]]
#[[Xolremdi]]

Revision as of 02:25, 13 June 2024

Kosar Doraghi, M.D.[1]

Kosar Doraghi, M.D.

Current Position

Associate Editor-in-Chief, Beth Israel Deaconess Medical Center by Harvard Medical School, Boston, Massachusetts, USA, WikiDoc Scholar


Pages Authored/Co-authored/Collaborated

  1. NEXOBRID
  2. RELYVRIO
  3. Deucravacitinib
  4. Ublituximab-xiiy
  5. futibatinib
  6. Tapinarof
  7. Spevigo- spesolimab-sbz
  8. Vericiguat
  9. Dasiglucagon
  10. Ponesimod
  11. Lasmiditan
  12. Nirogacestat
  13. Nedosiran
  14. Ryzneuta
  15. Endocarditis overview
  16. Sparsentan
  17. BRENZAVVY- bexagliflozin
  18. New GOLD 2024 Recommendation for Vaccination of COPD Patients
  19. Nirsevimab
  20. Xacduro- sulbactam and durlobactam
  21. EXXUA
  22. Somatrogon-ghla
  23. Chronic renal failure overview
  24. Aprocitentan
  25. WINREVAIR
  26. Xolremdi
Retrieved from "https://www.wikidoc.org/index.php?title=Template:KDRG&oldid=1737944"